http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009221037-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c01440556dd40f6f8f4042bcc1cd8f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c98c9ae6518d517660f0f91ca7fcd73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c16e1c811b667aa497d09459e6a3ee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f624623087fa9d6b9c35b69391c9b69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_147ee935125bd614d6304c5b54fe84cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eb9b0fce0c776512a26b2bab4a9a268
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-59
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
filingDate 2001-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bef2f34b864de9d39391ffe39474c66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08645a90c9c95482556f3ddfca6ab287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_398a8e8bb5489b6a64d6dcff58513ace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e77875749c3914bba5da332b50505385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83562cd3d230bc86fd09b650edf49668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd0f1c9c33cd23d23eae099d1cef0783
publicationDate 2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009221037-A1
titleOfInvention Fusion protein having the enhanced in vivo activity of erythropoietin
abstract The present invention relates to a fusion protein in which a carboxy terminal of human erythropoietin (EPO) is fused with a carboxy terminal peptide fragment of β subunit of human chorionic gonadotropin (HCG), to DNA encoding the fusion protein, and to a method for preparation of the fusion protein. The fusion protein has the enhanced in vivo activity of erythropoietin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522945-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197915-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9828417-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10538755-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10232020-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013096386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9908924-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10696726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221228-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9896494-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10119132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10351615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2922867-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946147-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9458444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10030060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3848386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9573987-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10640758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10960058-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2937362-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808534-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104114183-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10428129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014159813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11066658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593156-B2
priorityDate 2000-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5792460-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5759818-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5712122-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5585345-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127433622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID349960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128074315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14017587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411469

Total number of triples: 75.